Eva Hedlund
Principal Researcher | Docent
E-mail: eva.hedlund@ki.se
Visiting address: Solnavägen 9, 17165 Solna
Postal address: C5 Cell- och molekylärbiologi, C5 CMB Hedlund, 171 77 Stockholm
Research
- The lethal motor neuron diseases (MNDs) amyotrophic lateral sclerosis (ALS)
and spinal muscular atrophy (SMA) are defined by the loss of somatic motor
neurons that innervate muscles in arms, legs, trunk and face, leading to
muscle wasting. However, not all motor neurons are equally vulnerable;
certain groups of motor neurons are spared, including those in the oculomotor
nucleus, controlling eye movement and motor neurons in the Onuf's nucleus,
controlling pelvic muscles. The reasons for the differential vulnerability to
degeneration among motor neuron groups are unknown.
*Research in the Hedlund lab is aimed at elucidating mechanisms of neuronal
vulnerability and resistance with the goal of identifying new molecular
targets for the treatment of motor neuron diseases.*
Towards this goal, we utilize laser capture microdissection coupled with RNA
sequencing to dissect molecular pathways in distinct motor neuron populations
in animal models of MNDs. We also perform cross-disease analyses of
degenerative and regenerative axonal responses at neuromuscular junctions -
the specialized synapses between motor neurons and muscle.
Motor neuron cultures derived from embryonic stem cells (ESCs) and induced
pluripotent stem cells (iPSCs) harboring disease-inducing mutations are
coupled with microfluidics to model MNDs and study neuronal vulnerability and
protection in vitro. Finally, we modulate candidate gene expression in vivo
in transgenic MND mouse models to induce motor neuron protection and axonal
regeneration.
More information can be found on the lab web site. [1]
[1] http://ki.se/en/neuro/hedlund-laboratory
Articles
- Journal article: GENOME RESEARCH. 2025;35(9):1975-1991Mei I; Nichterwitz S; Leboeuf M; Nijssen J; Lenoel I; Repsilber D; Lobsiger CS; Hedlund E
- Journal article: NATURE COMMUNICATIONS. 2025;16(1):4633Schweingruber C; Nijssen J; Mechtersheimer J; Reber S; Leboeuf M; O'Brien NL; Mei I; Hedges E; Keuper M; Benitez JA; Radoi V; Jastroch M; Ruepp M-D; Hedlund E
- Journal article: BRAIN. 2025;148(4):1058-1061Corti S; Hedlund E
- Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024;78:54-63Barde S; Aguila J; Zhong W; Solarz A; Mei I; Prud'homme J; Palkovits M; Turecki G; Mulder J; Uhlen M; Nagy C; Mechawar N; Hedlund E; Hokfelt T
- Article: METHODS IN MOLECULAR BIOLOGY. 2023;2594:143-164Schweingruber C; Nijssen J; Benitez JA; Hedlund E
- Article: SKELETAL MUSCLE. 2022;12(1):22Woschitz V; Mei I; Hedlund E; Murray LM
- Article: CELL METABOLISM. 2021;33(11):2215-2230.e8Correia JC; Kelahmetoglu Y; Jannig PR; Schweingruber C; Shvaikovskaya D; Zhengye L; Cervenka I; Khan N; Stec M; Oliveira M; Nijssen J; Martinez-Redondo V; Ducommun S; Azzolini M; Lanner JT; Kleiner S; Hedlund E; Ruas JL
- Article: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2021;14:699562Aguila J; Cheng S; Kee N; Cao M; Wang M; Deng Q; Hedlund E
- Article: NATURE MEDICINE. 2021;27(4):640-646Manberg A; Skene N; Sanders F; Trusohamn M; Remnestal J; Szczepinska A; Aksoylu IS; Lonnerberg P; Ebarasi L; Wouters S; Lehmann M; Olofsson J; von Gohren Antequera I; Domaniku A; De Schaepdryver M; De Vocht J; Poesen K; Uhlen M; Anink J; Mijnsbergen C; Vergunst-Bosch H; Hubers A; Klappe U; Rodriguez-Vieitez E; Gilthorpe JD; Hedlund E; Harris RA; Aronica E; Van Damme P; Ludolph A; Veldink J; Ingre C; Nilsson P; Lewandowski SA
- Article: GLIA. 2021;69(1):124-136Boucanova F; Pollmeier G; Sandor K; Morado Urbina C; Nijssen J; Medard J-J; Bartesaghi L; Pellerin L; Svensson CI; Hedlund E; Chrast R
- Article: NATURE COMMUNICATIONS. 2020;11(1):6341Jutzi D; Campagne S; Schmidt R; Reber S; Mechtersheimer J; Gypas F; Schweingruber C; Colombo M; von Schroetter C; Loughlin FE; Devoy A; Hedlund E; Zavolan M; Allain FH-T; Ruepp M-D
- Article: GENOME RESEARCH. 2020;30(8):1083-1096Nichterwitz S; Nijssen J; Storvall H; Schweingruber C; Comley LH; Allodi I; van der Lee M; Deng Q; Sandberg R; Hedlund E
- Article: CELL REPORTS. 2020;31(9):107699Osman AM; Sun Y; Burns TC; He L; Kee N; Oliva-Vilarnau N; Alevyzaki A; Zhou K; Louhivuori L; Uhlen P; Hedlund E; Betsholtz C; Lauschke VM; Kele J; Blomgren K
- Article: ACTA NEUROPATHOLOGICA. 2020;139(5):837-853Nizzardo M; Taiana M; Rizzo F; Benitez JA; Nijssen J; Allodi I; Melzi V; Bresolin N; Comi GP; Hedlund E; Corti S
- Article: BIO-PROTOCOL. 2019;9(14):e3312Nijssen J; Aguila J; Hedlund E
- Article: STEM CELL REPORTS. 2019;12(6):1329-1341Allodi I; Nijssen J; Benitez JA; Schweingruber C; Fuchs A; Bonvicini G; Cao M; Kiehn O; Hedlund E
- Article: JOURNAL OF PHYSIOLOGY-LONDON. 2019;597(12):3133-3146Cheng AJ; Allodi I; Chaillou T; Schlittler M; Ivarsson N; Lanner JT; Thams S; Hedlund E; Andersson DC
- Article: HUMAN MOLECULAR GENETICS. 2019;28(10):1629-1644Sancho P; Bartesaghi L; Miossec O; Garcia-Garcia F; Ramirez-Jimenez L; Siddell A; Akesson E; Hedlund E; Lassuthova P; Pascual-Pascual SI; Sevilla T; Kennerson M; Lupo V; Chrast R; Espinos C
- Article: NATURE. 2019;567(7747):234-238Newton PT; Li L; Zhou B; Schweingruber C; Hovorakova M; Xie M; Sun X; Sandhow L; Artemov AV; Ivashkin E; Suter S; Dyachuk V; El Shahawy M; Gritli-Linde A; Bouderlique T; Petersen J; Mollbrink A; Lundeberg J; Enikolopov G; Qian H; Fried K; Kasper M; Hedlund E; Adameyko I; Savendahl L; Chagin AS
- Article: STEM CELL REPORTS. 2018;11(6):1565-1578Nijssen J; Aguila J; Hoogstraaten R; Kee N; Hedlund E
- Show more
All other publications
- Preprint: BIORXIV. 2025Cheng S; Aguila Benitez JC; Leboeuf M; Wang M; Mei I; Alcalde SG; Deng Q; Pernaute RS; Hedlund E
- Preprint: BIORXIV. 2025Leboeuf M; Nijssen J; Comley LH; Aguila Benitez JC; Mei I; Gómez Alcalde S; Radoi V; Nichterwitz S; Schweingruber C; Hedlund E; Cullheim S
- Preprint: BIORXIV. 2024Kee N; Leboeuf M; Gómez S; Petitpré C; Mei I; Benlefki S; Hagey D; Dias J; Lallemend F; Andaloussi SE; Ericson J; Hedlund E
- Preprint: BIORXIV. 2024Mei I; Nichterwitz S; Leboeuf M; Nijssen J; Lenoel I; Repsilber D; Lobsiger C; Hedlund E
- Letter: NEURON. 2023;111(23):3739-3741Gautier O; Blum JA; Maksymetz J; Chen D; Schweingruber C; Mei I; Hermann A; Hackos DH; Hedlund E; Ravits J; Gitler AD
- Preprint: BIORXIV. 2023Gautier O; Blum J; Maksymetz J; Chen D; Schweingruber C; Mei I; Hermann A; Hackos D; Hedlund E; Ravits J; Gitler A
- Preprint: BIORXIV. 2023Schweingruber C; Nijssen J; Mechtersheimer J; Reber S; Leboeuf M; O’Brien N; Mei I; Hedges E; Keuper M; Keuper M; Aguila Benitez J; Radoi V; Jastroch M; Ruepp M-D; Hedlund E
- Preprint: BIORXIV. 2022Barde S; Aguila J; Zhong W; Solarz A; Mei I; Prud’homme J; Palkovits M; Turecki G; Mulder J; Uhlén M; Nagy C; Mechawar N; Hedlund E; Hökfelt T
- Review: BIOLOGY-BASEL. 2022;11(8):1191Schweingruber C; Hedlund E
- Corrigendum: NATURE MEDICINE. 2021;27(7):1308Manberg A; Skene N; Sanders F; Trusohamn M; Remnestal J; Szczepinska A; Aksoylu IS; Lonnerberg P; Ebarasi L; Wouters S; Lehmann M; Olofsson J; von Gohren Antequera I; Domaniku A; De Schaepdryver M; De Vocht J; Poesen K; Uhlen M; Anink J; Mijnsbergen C; Vergunst-Bosch H; Hubers A; Klappe U; Rodriguez-Vieitez E; Gilthorpe JD; Hedlund E; Harris RA; Aronica E; Van Damme P; Ludolph A; Veldink J; Ingre C; Nilsson P; Lewandowski SA
- Preprint: BIORXIV. 2021Correia JC; Kelahmetoglu Y; Jannig PR; Schweingruber C; Svaikovskaya D; Zhengye L; Cervenka I; Oliveira M; Nijssen J; Martínez-Redondo V; Stec M; Khan N; Lanner JT; Kleiner S; Hedlund E; Ruas JL
- Preprint: BIORXIV. 2020Aguila J; Cheng S; Kee N; Cao M; Deng Q; Hedlund E
- Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1479-1480Sancho P; Bartesaghi L; Moissec O; Garcia-Garcia F; Ramirez-Jimenez L; Siddell A; Akesson E; Hedlund E; Lassuthova P; Pascual-Pascual S; Sevilla T; Kennerson M; Lupo V; Chrast R; Espinos C
- Conference publication: HUMAN GENE THERAPY. 2018;29(12):A7Hedlund E
- Preprint: BIORXIV. 2018Allodi I; Nijssen J; Benitez JA; Schweingruber C; Fuchs A; Bonvicini G; Cao M; Kiehn O; Hedlund E
- Preprint: BIORXIV. 2018Nichterwitz S; Storvall H; Nijssen J; Comley LH; Allodi I; van der Lee M; Schweingruber C; Deng Q; Sandberg R; Hedlund E
- Preprint: BIORXIV. 2018Aguila J; Cheng S; Kee N; Cao M; Wang M; Deng Q; Hedlund E
- Preprint: BIORXIV. 2018Nijssen J; Benitez JA; Hoogstraaten R; Kee N; Hedlund E
- Review: MOLECULAR ASPECTS OF MEDICINE. 2018;59:36-46Hedlund E; Deng Q
- Preprint: SSRN ELECTRONIC JOURNAL. 2018Nijssen J; Benitez JA; Hoogstraaten R; Kee N; Hedlund E
- Show more
Grants
- Swedish Research Council1 January 2025 - 31 December 2028Motor neurons (MNs) and skeletal muscle fibers need to maintain bidirectional communication to avoid synaptic breakdown and systemic failure of motor control. However, we do not understand what meditors regulate their communication. In addition to communication over their synapse, the neuromuscular junction (NMJ), MN and muscle are thought to rely on autocrine, paracrine and endocrine signals, which are largely unknown. In the lethal disease ALS, the NMJ is the first pathological target with subsequent axonal degeneration, followed by muscle atrophy and paralysis. Recent evidence strongly suggests that there is systemic dysregulation of energy metabolism in ALS and that multiple cell types may contribute early on to MN pathology, but the underlying molecular mechanisms are unknown. As MNs have high energy demand, impairments in energy metabolism of multiple cell types that MNs rely upon could explain their selective degeneration in ALS. Our hypothesis is that in ALS, dysregulation of energy metabolism of multiple cell types synergistically provoke disturbances in cell-cell communication, causing disruption of the NMJ with subsequent MN degeneration. We will investigate how human MNs, muscle, oligodendrocytes, astrocytes and fuel-supplying tissues communicate to support neuromuscular function and how disease-related disruption in bioenergetic leads to subsequent miscommunication between multiple cell types promoting collapse of the NMJ and consequently leading to ALS.
- Swedish Research Council1 January 2021 - 31 December 2024
- Swedish Research Council1 December 2018 - 31 December 2021
- Swedish Research Council1 January 2017 - 31 December 2020
- JPND utlysning 2013. Cross-Disease analysis of pathways. DAMNDPATHS, Elucidation of common transcriptional targets in vulnerable DopAmine, MotorNeuron and frontotemporal Dementia disease PATHwaySSwedish Research Council1 December 2014 - 31 December 2016
- Swedish Research Council1 January 2012 - 31 December 2014
- Hjärnfonden
Employments
- Principal Researcher, Department of Cell and Molecular Biology, Karolinska Institutet, 2023-
Degrees and Education
- Docent, karolinska institutet, 2011
- Doctor Of Philosophy, - No translation available -, Karolinska Institutet, 2000